Stocks of the Hour: Golden Deeps, Noxopharm, Echo IQ
Stocks of the Hour: Golden Deeps, Noxopharm, Echo IQ
Golden Deeps (ASX:GED) has announced that thick copper and zinc sulphide mineralisation has been intersected in diamond drilling of key targets at the Company's Havilah Project. The results up to 18.5% Copper & 34.8% Zinc in initial pXRF readings. Shares are trading 157.14 per cent higher at 7.2 cents.
Golden Deeps（ASX:GED）宣布，在公司的Havilah项目的关键目标进行的金刚石钻探中，已经交叉了厚厚的铜和硫化锌矿化物。最初pXRF读数显示铜含量高达18.5%和锌含量达34.8%。股价上涨157.14%，每股7.2美分。
Innovative biotech company Noxopharm (ASX:NOX) has announced substantial progress on its Chroma technology platform, with encouraging brain cancer results plus early work on leukaemia. The Chroma drug development program focuses on generating promising novel anticancer drugs. Shares are trading 23.81 per cent higher at 13 cents.
创新生物科技公司Noxopharm（ASX:NOX）宣布其Chroma科技平台取得重大进展，取得令人鼓舞的脑癌研究成果，以及对白血病的早期工作。Chroma药物开发计划专注于生成有前景的新型抗癌药物。股价上涨23.81%，每股13美分。
Echo IQ (ASX:EIQ) is pleased to provide the following overview of positive results from two recently completed clinical studies, which highlight the effectiveness of its AI-backed solution for heart failure when compared to an observed detection rate of 46% in clinical practice. Shares are trading 10 per cent higher at 16.5 cents.
Echo IQ（ASX:EIQ）很高兴地介绍了最近完成的两项临床研究的积极结果概述，这些研究强调了其人工智能支持的心力衰竭解决方案的有效性，与临床实践中46%的观测检测率相比。股价上涨10%，每股16.5美分。